ֱ

Clinical Challenges

ESMO: Metastatic Breast Cancer

European Society for Medical Oncology

More in ESMO: Metastatic Breast Cancer

Clinical Challenges: Test Your Knowledge on New Breast Cancer Treatments

A three-part quiz covering our series on advanced breast cancer

Nov 26, 2023
A blue and pink neon sign with the words QUIZ TIME
Clinical Challenges: Sequencing in Metastatic TNBC

It may only get more complicated as new options are approved

Nov 26, 2023
ESMO over a photo of IFEMA Madrid in Spain.
Clinical Challenges: Sequencing in Metastatic, HER2-Positive Breast Cancer

Data have narrowed first- and second-line choices, but decisions must be tailored to the patient

Nov 21, 2023
ESMO over a photo of IFEMA Madrid in Spain.
Clinical Challenges: Managing Toxicities of Newer Breast Cancer Therapies

Antibody-drug conjugates in particular may present clinicians with less familiar side effects

Nov 15, 2023
ESMO over a photo of IFEMA Madrid in Spain.
Clinical Challenges: Test Your Knowledge on Metastatic Breast Cancer

A three-question quiz on HER2-low disease, brain metastases, and progression on CDK4/6 inhibitors

Sep 30, 2022
A blue and pink neon sign with the words QUIZ TIME
Clinical Challenges: Options After CDK4/6 Inhibitors in Breast Cancer

Rapidly changing landscape has brought new targeted agents and made staying up-to-date vital

Sep 30, 2022
ESMO over a photo of Venue Porte de Versailles, Paris France
Clinical Challenges: The Low-Down on HER2-Low

The new category could encompass a majority of metastatic, unresectable breast cancers

Sep 09, 2022
ESMO over a photo of Venue Porte de Versailles, Paris France
Clinical Challenges: When to Start End-of-Life Care in Metastatic Breast Cancer

Some patients live years with advanced disease; when should end-of-life care talks happen?

Sep 30, 2021
ESMO over a computer rendering of a tumor.